You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Serotonin 5-HT2 Receptor Antagonists

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Implication of 5-HT7 Receptor in Inflammatory Mechanisms in

Not yet recruiting
  • Healthy
  • Multiple Sclerosis
  • Blood sample
  • Orléans, France
    CHR Orléans
Feb 16, 2023

Breast Cancer, Chemo-induced Nausea and Vomiting Trial in Hanzhou (Aprepitant, Palonosetron, Fosaprepitant)

Not yet recruiting
  • Breast Cancer
  • Chemotherapy-induced Nausea and Vomiting
  • Hanzhou, Zhejiang, China
    the Second Affiliated Hospital of Zhejiang Univercity School of
Apr 23, 2023

Pediatric Cancer Trial in Yerevan (Ondansetron, Dexamethasone)

Not yet recruiting
  • Pediatric Cancer
  • Yerevan, Armenia
    Hematology Center named after prof. R. Yeolyan
May 23, 2023

5-HT7 Receptor Implication in Inflammatory Mechanisms in

Completed
  • Multiple Sclerosis, Acute Relapsing
  • Multiple Sclerosis
  • blood sampling
  • Orléans, France
    CHR Orléans
Feb 16, 2022

Healthy Trial in Basel (Placebo, Mescaline 100mg, Mescaline 200mg)

Recruiting
  • Healthy
  • Placebo
  • +5 more
  • Basel, BS, Switzerland
    University Hospital Basel, Clinical Trial Unit
Aug 17, 2021

Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%

Not yet recruiting
  • Acneiform Eruption Due to Chemical
  • +2 more
  • HT-001 2% Topical Gel
  • +3 more
  • (no location specified)
Dec 3, 2022

Depressive Symptoms, Depression, Alzheimer Trial in Baltimore (Psilocybin)

Recruiting
  • Depressive Symptoms
  • +3 more
  • Baltimore, Maryland
    Behavioral Pharmacology Research Unit
Mar 9, 2022

Chemo-induced Nausea and Vomiting Trial in Chengdu (5HT3RA+Olanzapine, 5HT3RA+Olanzapine+Dexamethasone)

Recruiting
  • Chemotherapy-induced Nausea and Vomiting
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Mar 27, 2023

Healthy Trial in Chengdu (ATD treatment, treatment)

Unknown status
  • Healthy
  • ATD treatment
  • placebo treatment
  • Chengdu, Sichuan, China
    School of Life Science and Technology
Dec 20, 2020

Constipation Trial (acupuncture, Prucalopride)

Completed
Has Results
  • Constipation
  • (no location specified)
Feb 24, 2021

Basic Science Trial in Copenhagen (Lysergic Acid Diethylamide Tartrate)

Not yet recruiting
  • Basic Science
  • Lysergic Acid Diethylamide Tartrate
  • Copenhagen, Denmark
    Neurobiology Research Unit, Rigshospitalet
Jul 11, 2023

Tourette Disorder Trial in Bron, Paris (Administration of a PET radiotracer)

Not yet recruiting
  • Tourette Disorder
  • Administration of a PET radiotracer
  • Bron, France
  • +1 more
Jul 12, 2023

Schizophrenia Trial in Rockville (Lu AF35700)

Completed
Has Results
  • Schizophrenia
  • Lu AF35700
  • Rockville, Maryland
    US802
May 11, 2020

Postoperative Nausea and Vomiting, Anesthesia Complication, Thoracic Diseases Trial (Ondansetron 8mg, Fosaprepitant 150 mg)

Not yet recruiting
  • Postoperative Nausea and Vomiting
  • +2 more
  • Ondansetron 8mg
  • Fosaprepitant 150 mg
  • (no location specified)
Jun 4, 2023

Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010; paliperidone palmitate, INVEGA SUSTENNA)

Active, not recruiting
  • Schizophrenia
  • +11 more
  • LY03010; paliperidone palmitate
  • INVEGA SUSTENNA
  • Garden Grove, California
  • +8 more
Nov 19, 2021

Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010 156 mg treatment group, deltoid, LY03010 156

Recruiting
  • Schizophrenia
  • +11 more
  • LY03010 156 mg treatment group, deltoid
  • +3 more
  • Little Rock, Arkansas
  • +8 more
Apr 11, 2022

Parkinson Disease Trial in France (drug, behavioral, procedure)

Recruiting
  • Parkinson Disease
  • Active drug: pimavanserin 17mg (2 strength tablets)
  • +9 more
  • Besançon, France
  • +15 more
Jan 20, 2022

Peripheral Serotonin and Albinism

Not yet recruiting
  • Oculocutaneous Albinism
  • Dosage of serotonin and metabolites
  • Blood parameters
  • Paris, France
    Hôpital Necker-Enfants Malades
Nov 14, 2023

Postoperative Nausea and Vomiting, Laparoscopic Cholecystectomy Trial in Tanta (Ondansetron 4mg + dexmedetomidine 0.5 ug/kg +

Recruiting
  • Postoperative Nausea and Vomiting
  • Laparoscopic Cholecystectomy
  • Ondansetron 4mg + dexmedetomidine 0.5 ug/kg + normal saline .
  • Ondansetron 4mg + dexamethasone 8mg + normal saline.
  • Tanta, Algharbia, Egypt
    Tanta University hospitals
Aug 26, 2023

Bipolar Depression, Bipolar Affective Disorder Trial (NRX-101)

Available
  • Bipolar Depression
  • Bipolar Affective Disorder
  • (no location specified)
Mar 22, 2023

Atypical Antipsychotics inGeriatric Population: What is Role of

Recruiting
  • Neutropenia
    • Strasbourg, France
      Service de Pharmacie - Stérilisation - CHU de Strasbourg - Franc
    Oct 27, 2023

    Neurodegenerative Diseases, Parkinson Disease, Parkinson Disease Psychosis Trial (Pimavanserin)

    Recruiting
    • Neurodegenerative Diseases
    • +2 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jan 24, 2023

    Depression, Serotonin Deficiency Trial in Kelowna (Pharmacological agent: Citalopram, Placebo)

    Not yet recruiting
    • Depression
    • Serotonin Deficiency
    • Pharmacological agent: Citalopram
    • Placebo
    • Kelowna, British Columbia, Canada
      University of British Columbia, Okanagan Campus
    Jul 19, 2023

    Basic Science Trial in Copenhagen (Psilocybine, Ketanserin)

    Recruiting
    • Basic Science
    • Copenhagen, Denmark
      Neurobiology Research Unit, Rigshospitalet
    Aug 11, 2022

    Chemo-induced Nausea and Vomiting Trial in Chapel Hill (Olanzapine 5 MG, Placebo)

    Completed
    • Chemotherapy-induced Nausea and Vomiting
    • Olanzapine 5 MG
    • Placebo
    • Chapel Hill, North Carolina
      UNC Hospital
    Nov 28, 2022